Effects of an Alternative Treatment for Military Sexual Trauma on PTSD Symptoms, Neurosteroids and Brain Function
NCT ID: NCT00374738
Last Updated: 2016-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2006-11-30
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To examine the efficacy of GIFT in improving MST-related clinical outcomes in women veterans
2. To examine the effects of GIFT on fronto-limbic brain function and
3. To examine the effects of GIFT on levels of neuroactive steroid associated with PTSD.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Guided Imagery for Military Sexual Trauma-Related Posttraumatic Stress Disorder (PTSD)
NCT00635635
Pathophysiological Understanding and Treatment of PTSD: an rTMS Approach
NCT03840369
3MDR to Treat PTSD With mTBI (3MDR)
NCT03796936
Transcranial Magnetic Stimulation in Veterans With PTSD
NCT07336251
Treatment for Veterans With Military Sexual Trauma
NCT00371644
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To address this issue, we will evaluate a guided imagery intervention for women veterans who have MST-related PTSD. We will evaluate the efficacy of Guided Imagery for Trauma (GIFT) in decreasing PTSD symptoms. Using brain-imaging techniques, this research will examine the effects of GIFT on brain function in the areas associated with PTSD. We will also examine the effects of GIFT on neurosteroids, which are candidate modulators of PTSD symptoms, and may also represent novel targets for therapeutic intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GIFT Intervention
Guided Imagery for Trauma (GIFT)
Guided Imagery for Trauma (GIFT)
Guided Imagery for Trauma (GIFT) - music and voice narration over a 12-week intervention. The control intervention included a relaxing music audio (the same music used in the guided imagery audio but without the narrative voiceover), PDA to log audio use, orientation and weekly phone consults, but did not have access to the patient advocate or to the guided imagery instructions provided on the GIFT audio.
Music Control
Relaxing Music Audio control; same music used in guided imagery, with no narrative voice.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Guided Imagery for Trauma (GIFT)
Guided Imagery for Trauma (GIFT) - music and voice narration over a 12-week intervention. The control intervention included a relaxing music audio (the same music used in the guided imagery audio but without the narrative voiceover), PDA to log audio use, orientation and weekly phone consults, but did not have access to the patient advocate or to the guided imagery instructions provided on the GIFT audio.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Status as a woman veteran
* Receives care at the Durham VAMC
* History of MST
* DSM-IV diagnosis of PTSD, confirmed by CAPS interview
* Able to participate in a research interview in English
* Regular telephone access
Exclusion Criteria
* Suicidality or parasuicidality
* Ongoing family violence
* Alcohol or drug dependence within previous 3 months
* Enrolled in cognitive-behavioral/exposure-based therapy during study period.
* Supportive therapy and psychiatric medications (if stabilized at least 3 months prior to enrollment) are acceptable.
* An uncontrolled medical condition
* Foreign metallic objects or implanted devices in the body incompatible with MRI
* Positive pregnancy test as determined by serum ß-HCG level
* Claustrophobia
* CNS neoplasms or neurological conditions such as Parkinson's Disease, Huntington's Chorea, demyelinating diseases, seizures, hydrocephalus, etc.
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Durham VA Medical Center
FED
Samueli Institute for Information Biology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer L. Strauss, PhD
Role: PRINCIPAL_INVESTIGATOR
Duke University Medical Center & Durham VA Medical Center
Christine Marx, MD, MA
Role: PRINCIPAL_INVESTIGATOR
Duke University Medical Center & Durham VA Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Women Veterans' Comprehensive Health Center (WVCHC) @ Durham Veterans Affairs Medical Center (DVAMC)
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DUHS Protocol No. 5023-05-10R2
Identifier Type: OTHER
Identifier Source: secondary_id
NC181BO-1 (IRB #01012)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.